The study showed that autophagy induction by silibinin positively contributing to its anti-metastatic capacity in human RCC cells (ACHN and 786-O) by increasing the expression of LC3-II and enrichment of autophagolysosome vacuoles via the AMPK/mTOR pathway (F. Li et al., 2015). This evidence concerns the gene MTOR and renal cell carcinoma.